INOVIQ Limited Bell Potter Healthcare Conference 2022

INOVIQ is developing next-generation exosome capture tools and precision diagnostics for cancer detection and monitoring. The company's proprietary technology platforms target breast, ovarian, and bladder cancers across a $15 billion global market, with multiple products in development and key inflection points anticipated over the following 12 months.